相关实验视频

Updated: Jun 14, 2025

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

G2/M检查点调制:在FAM和乳腺癌中的miRNA配置文件的洞察力

Sofia Mubarika Haryana¹, Syamsul Arif Ardiansyah², Habibullah Noficandra²

¹Study Program of Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Asian Pacific journal of cancer prevention : APJCP

|August 29, 2024

概括

在Luminal A乳腺癌中,微RNA (miRNA) 概况与Fibroadenoma mamae (FAM) 相比显示出显著的差异. 确定了调节G2M检查点的特定miRNA,提供了潜在的生物标志物和治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

乳腺癌是一种异质性疾病,Luminal A代表一个主要的亚型.
微RNAs (miRNAs) 是基因表达的关键调节者,在癌症发育中发挥关键作用.
了解miRNA参与细胞循环调节对于确定新的治疗策略至关重要.

研究的目的:

调查miRNA在细胞循环调节中的作用,特别是G2M检查点,在印尼人口的Luminal A乳腺癌中.
为了确定潜在的miRNA生物标志物和治疗点的光线A乳腺癌.
在Luminal A和Fibroadenoma mamae (FAM) 样本之间比较miRNA表达特征.

主要方法:

微RNA的差异表达分析使用纳米链nCounter技术在形式固式嵌 (FFPE) 组织上.
从FFPE Luminal A和FAM样本中分离RNA.
使用KEGG和GSEA MsigDB数据库进行路径和基因调节分析,并通过Cytoscape,NetworkAnalyst和SRplot进行数据可视化.

主要成果:

在792个检测到的miRNA中,与FAM相比,在Luminal A中60个是上调的,6个是下调的.
十五个上调的miRNA与G2M检查点调节有关.
发现五种特定的miRNAs (hsa-miR-196b-5p,hsa-miR-218-5p,hsa-miR-7-5p,hsa-miR-19a-5p和hsa-miR-18a-5p) 通过准CDKN1B基因来显著调节G2M检查点.

结论:

在Luminal A和FAM样本之间存在miRNA表达的显著差异.
一些已识别的miRNAs调节Luminal A乳腺癌中的G2M检查点.
这些miRNAs代表潜在的治疗点,可能通过抑制瘤抑制基因.

关键词:

在G2M检查站.关键词: 灯光 A 灯光 A 微RNA 分析微RNA 分析纳米链 n 计数器计数器

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.